Cell-derived viral vaccines with low levels of residual cell DNA by betapropiolactone treatment

Details for Australian Patent Application No. 2011201968 (hide)

Owner Novartis Vaccines and Diagnostics GmbH & Co. KG

Inventors Gregersen, Jens-Peter; Kost, Holger

Agent FB Rice

Pub. Number AU-A-2011201968

Parent 2006310171

Filing date 29 April 2011

Wipo publication date 19 May 2011

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

19 May 2011 Application Open to Public Inspection

  Published as AU-A-2011201968

19 May 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201969-Ear tag installation tool and method

2011201967-Immuno-amplification